Efflux transporters in blood-brain interfaces of the developing brain

Frontiers in Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Strazielle, Nathalie ^a,b   Ghersi Egea, Jean François ^b  

^a Brain i   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

ABC transporter; Blood brain barrier; Choroid plexus; Development; Hypoxia; Perinatal injury; SLC transporter; Xenobiotic

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARNITINE TRANSPORTER 2; CARRIER PROTEINS AND BINDING PROTEINS; GLUCOSE TRANSPORTER 1; MESSENGER RNA; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 4; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 7; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 5; MULTIDRUG RESISTANCE PROTEIN 9; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER B; ORGANIC ANION TRANSPORTER D; ORGANIC CATION TRANSPORTER 2; PEPTIDE TRANSPORTER 2; PROSTAGLANDIN TRANSPORTER; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A2; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A4; SOLUTE CARRIER ORGANIC ANION TRANSPORTER 1A5; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; FAMILY; HUMAN; INFLAMMATION; NEURAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW;

EID: 84949117688     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00021     Document Type: Review

References (90)

1. Abbott, N. J., Ronnback, L., and Hansson, E. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53. doi: 10.1038/nrn1824
2. Aden, U., Favrais, G., Plaisant, F., Winerdal, M., Felderhoff-Mueser, U., Lampa, J., et al. (2010). Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain. Behav. Immun. 24, 747-758. doi: 10.1016/j.bbi.2009.10.010
3. Alebouyeh, M., Takeda, M., Onozato, M. L., Tojo, A., Noshiro, R., Hasannejad, H., et al. (2003). Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J. Pharmacol. Sci. 93, 430-436. doi: 10.1254/jphs.93.430
4. Alvarez, J. I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P. J., Terouz, S., et al. (2011). The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334, 1727-1731. doi: 10.1126/science.1206936
5. Angeletti, R. H., Bergwerk, A. J., Novikoff, P. M., and Wolkoff, A. W. (1998). Dichotomous development of the organic anion transport protein in liver and choroid plexus. Am. J. Physiol. 275, C882-C887.
6. Armulik, A., Genove, G., Mae, M., Nisancioglu, M. H., Wallgard, E., Niaudet, C., et al. (2010). Pericytes regulate the blood-brain barrier. Nature 468, 557-561. doi: 10.1038/nature09522
7. Baello, S., Iqbal, M., Bloise, E., Javam, M., Gibb, W., and Matthews, S. G. (2014). TGF-beta1 regulation of multidrug resistance P-glycoprotein in the developing male blood-brain barrier. Endocrinology 155, 475-484. doi: 10.1210/en.2013-1472
8. Batisson, M., Strazielle, N., Hejmadi, M., Thomas, D., Ghersi-Egea, J. F., Etienne, J., et al. (2006). Toxic shock syndrome toxin-1 challenges the neuroprotective functions of the choroidal epithelium and induces neurotoxicity. J. Infect. Dis. 194, 341-349. doi: 10.1086/505428
9. Bauer, H. C., and Bauer, H. (2000). Neural induction of the blood-brain barrier: still an enigma. Cell. Mol. Neurobiol. 20, 13-28. doi: 10.1023/A:1006939825857
10. Betz, A. L., and Goldstein, G. W. (1981). Developmental changes in metabolism and transport properties of capillaries isolated from rat brain. J. Physiol. 312, 365-376. doi: 10.1113/jphysiol.1981.sp013633
11. Bronger, H., Konig, J., Kopplow, K., Steiner, H. H., Ahmadi, R., Herold-Mende, C., et al. (2005). ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood-tumor barrier. Cancer Res. 65, 11419-11428. doi: 10.1158/0008-5472.CAN-05-1271
12. Caley, D. W., and Maxwell, D. S. (1970). Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex. J. Comp. Neurol. 138, 31-47. doi: 10.1002/cne.901380104
13. Cooray, H. C., Blackmore, C. G., Maskell, L., and Barrand, M. A. (2002). Localisation of breast cancer resistance protein in microvessel endothelium of human brain. Neuroreport 13, 2059-2063. doi: 10.1097/00001756-200211150-00014
14. Daneman, R., Zhou, L., Agalliu, D., Cahoy, J. D., Kaushal, A., and Barres, B. A. (2010a). The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS ONE 5:e13741. doi: 10.1371/journal.pone.0013741
15. Daneman, R., Zhou, L., Kebede, A. A., and Barres, B. A. (2010b). Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468, 562-566. doi: 10.1038/nature09513
16. D'Angelo, B., Ek, C. J., Sandberg, M., and Mallard, C. (2013). Expression of the Nrf2-system at the blood-CSF barrier is modulated by neonatal inflammation and hypoxia-ischemia. J. Inherit. Metab. Dis. 36, 479-490. doi: 10.1007/s10545-012-9551-5
17. Daniel, H., and Rubio-Aliaga, I. (2003). An update on renal peptide transporters. Am. J. Physiol. Renal Physiol. 284, F885-F892. doi: 10.1152/ajprenal.00123.2002
18. Daood, M., Tsai, C., Ahdab-Barmada, M., and Watchko, J. F. (2008). ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS. Neuropediatrics 39, 211-218. doi: 10.1055/s-0028-1103272
19. Dauchy, S., Dutheil, F., Weaver, R. J., Chassoux, F., Daumas-Duport, C., Couraud, P. O., et al. (2008). ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J. Neurochem. 107, 1518-1528. doi: 10.1111/j.1471-4159.2008.05720.x
20. Ek, C. J., Wong, A., Liddelow, S. A., Johansson, P. A., Dziegielewska, K. M., and Saunders, N. R. (2010). Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat. Toxicol. Lett. 197, 51-59. doi: 10.1016/j.toxlet.2010.04.025
21. Fenart, L., Buee-Scherrer, V., Descamps, L., Duhem, C., Poullain, M. G., Cecchelli, R., et al. (1998). Inhibition of P-glycoprotein: rapid assessment of its implication in blood-brain barrier integrity and drug transport to the brain by an in vitro model of the blood-brain barrier. Pharm. Res. 15, 993-1000. doi: 10.1023/A:1011913723928
22. Ferriero, D. M. (2001). Oxidant mechanisms in neonatal hypoxia-ischemia. Dev. Neurosci. 23, 198-202. doi: 10.1159/000046143
23. Gaillard, P. J., Van Der Sandt, I. C., Voorwinden, L. H., Vu, D., Nielsen, J. L., De Boer, A. G., et al. (2000). Astrocytes increase the functional expression of P-glycoprotein in an in vitro model of the blood-brain barrier. Pharm. Res. 17, 1198-1205. doi: 10.1023/A:1026406528530
24. Gao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., and Meier, P. J. (2000). Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 294, 73-79.
25. Gao, B., Stieger, B., Noe, B., Fritschy, J. M., and Meier, P. J. (1999). Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J. Histochem. Cytochem. 47, 1255-1264. doi: 10.1177/002215549904701005
26. Gazzin, S., Berengeno, A. L., Strazielle, N., Fazzari, F., Raseni, A., Ostrow, J. D., et al. (2011). Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat. PLoS ONE 6:e16165. doi: 10.1371/journal.pone.0016165
27. Gazzin, S., Strazielle, N., Schmitt, C., Fevre-Montange, M., Ostrow, J. D., Tiribelli, C., et al. (2008). Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J. Comp. Neurol. 510, 497-507. doi: 10.1002/cne.21808
28. Ghersi-Egea, J. F., Monkkonen, K. S., Schmitt, C., Honnorat, J., Fevre-Montange, M., and Strazielle, N. (2009). Blood-brain interfaces and cerebral drug bioavailability. Rev. Neurol. (Paris) 165, 1029-1038. doi: 10.1016/j.neurol.2009.09.011
29. Ghersi-Egea, J. F., Strazielle, N., Murat, A., Jouvet, A., Buenerd, A., and Belin, M. F. (2006). Brain protection at the blood-cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism. J. Cereb. Blood Flow Metab. 26, 1165-1175. doi: 10.1038/sj.jcbfm.9600267
30. Goralski, K. B., Acott, P. D., Fraser, A. D., Worth, D., and Sinal, C. J. (2006). Brain cyclosporin A levels are determined by ontogenic regulation of mdr1a expression. Drug. Metab. Dispos. 34, 288-295. doi: 10.1124/dmd.105.007427
31. Hagenbuch, B., and Stieger, B. (2013). The SLCO (former SLC21) superfamily of transporters. Mol. Aspects Med. 34, 396-412. doi: 10.1016/j.mam.2012.10.009
32. Harati, R., Benech, H., Villegier, A. S., and Mabondzo, A. (2012a). P-glycoprotein, breast cancer resistance protein, Organic Anion Transporter 3, and Transporting Peptide 1a4 during blood-brain barrier maturation: involvement of Wnt/beta-catenin and endothelin-1 signaling. Mol. Pharm. 10, 1566-1580. doi: 10.1021/mp300334r
33. Harati, R., Villegier, A. S., Banks, W. A., and Mabondzo, A. (2012b). Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity. J. Neuroinflammation 9, 273. doi: 10.1186/1742-2094-9-273
34. Hartz, A. M., and Bauer, B. (2010). Regulation of ABC transporters at the blood-brain barrier: new targets for CNS therapy. Mol. Interv. 10, 293-304. doi: 10.1124/mi.10.5.6
35. Huber, R. D., Gao, B., Sidler Pfandler, M. A., Zhang-Fu, W., Leuthold, S., Hagenbuch, B., et al. (2007). Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am. J. Physiol. Cell Physiol. 292, C795-C806. doi: 10.1152/ajpcell.00597.2005
36. Kaindl, A. M., Favrais, G., and Gressens, P. (2009). Molecular mechanisms involved in injury to the preterm brain. J. Child Neurol. 24, 1112-1118. doi: 10.1177/0883073809337920
37. Keller, A. (2013). Breaking and building the wall: the biology of the blood-brain barrier in health and disease. Swiss Med. Wkly 143:w13892. doi: 10.4414/smw.2013.13892
38. Khuth, S. T., Strazielle, N., Giraudon, P., Belin, M. F., and Ghersi-Egea, J. F. (2005). Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2. J. Neurochem. 94, 1580-1593. doi: 10.1111/j.1471-4159.2005.03309.x
39. Kikuchi, R., Kusuhara, H., Sugiyama, D., and Sugiyama, Y. (2003). Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. J. Pharmacol. Exp. Ther. 306, 51-58. doi: 10.1124/jpet.103.049197
40. Koepsell, H. (2013). The SLC22 family with transporters of organic cations, anions and zwitterions. Mol. Aspects Med. 34, 413-435. doi: 10.1016/j.mam.2012.10.010
41. Kratzer, I., Liddelow, S. A., Saunders, N. R., Dziegielewska, K. M., Strazielle, N., and Ghersi-Egea, J. F. (2013). Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS 10:25. doi: 10.1186/2045-8118-10-25
42. Kratzer, I., Vasiljevic, A., Rey, C., Fevre-Montange, M., Saunders, N., Strazielle, N., et al. (2012). Complexity and developmental changes in the expression pattern of claudins at the blood-CSF barrier. Histochem. Cell. Biol. 138, 861-879. doi: 10.1007/s00418-012-1001-9
43. Kubota, H., Ishihara, H., Langmann, T., Schmitz, G., Stieger, B., Wieser, H. G., et al. (2006). Distribution and functional activity of P-glycoprotein and multidrug resistance-associated proteins in human brain microvascular endothelial cells in hippocampal sclerosis. Epilepsy Res. 68, 213-228. doi: 10.1016/j.eplepsyres.2005.11.011
44. Kusuhara, H., He, Z., Nagata, Y., Nozaki, Y., Ito, T., Masuda, H., et al. (2003). Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm. Res. 20, 720-727. doi: 10.1023/A:1023473216759
45. Landrigan, P. J., and Goldman, L. R. (2011). Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff. (Millwood) 30, 842-850. doi: 10.1377/hlthaff.2011.0151
46. Leggas, M., Adachi, M., Scheffer, G. L., Sun, D., Wielinga, P., Du, G., et al. (2004). Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol. Cell Biol. 24, 7612-7621. doi: 10.1128/MCB.24.17.7612-7621.2004
47. Leslie, E. M., Deeley, R. G., and Cole, S. P. (2005). Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol. Appl. Pharmacol. 204, 216-237. doi: 10.1016/j.taap.2004.10.012
48. Liddelow, S. A., Dziegielewska, K. M., Ek, C. J., Habgood, M. D., Bauer, H., Bauer, H. C., et al. (2013). Mechanisms that determine the internal environment of the developing brain: a transcriptomic, functional and ultrastructural approach. PLoS ONE 8:e65629. doi: 10.1371/journal.pone.0065629
49. Liebner, S., Czupalla, C. J., and Wolburg, H. (2011). Current concepts of blood-brain barrier development. Int. J. Dev. Biol. 55, 467-476. doi: 10.1387/ijdb.103224sl
50. Lim, J. C., Kania, K. D., Wijesuriya, H., Chawla, S., Sethi, J. K., Pulaski, L., et al. (2008). Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells. J. Neurochem. 106, 1855-1865. doi: 10.1111/j.1471-4159.2008.05537.x
51. Martin, V., Xu, J., Pabbisetty, S. K., Alonso, M. M., Liu, D., Lee, O. H., et al. (2009). Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transporters. Oncogene 28, 2358-2363. doi: 10.1038/onc.2009.103
52. Matsuoka, Y., Okazaki, M., Kitamura, Y., and Taniguchi, T. (1999). Developmental expression of P-glycoprotein (multidrug resistance gene product) in the rat brain. J. Neurobiol. 39, 383-392.
53. Miodovnik, A. (2011). Environmental neurotoxicants and developing brain. Mt. Sinai J. Med. 78, 58-77. doi: 10.1002/msj.20237
54. Mizee, M. R., Wooldrik, D., Lakeman, K. A., Van Het Hof, B., Drexhage, J. A., Geerts, D., et al. (2013). Retinoic acid induces blood-brain barrier development. J. Neurosci. 33, 1660-1671. doi: 10.1523/JNEUROSCI.1338-12.2013
55. Mori, S., Takanaga, H., Ohtsuki, S., Deguchi, T., Kang, Y. S., Hosoya, K., et al. (2003). Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. J. Cereb. Blood Flow Metab. 23, 432-440. doi: 10.1097/00004647-200304000-00007
56. Nagata, Y., Kusuhara, H., Endou, H., and Sugiyama, Y. (2002). Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol. Pharmacol. 61, 982-988. doi: 10.1124/mol.61.5.982
57. Nehlig, A., Pereira De Vasconcelos, A., and Boyet, S. (1989). Postnatal changes in local cerebral blood flow measured by the quantitative autoradiographic [14C]iodoantipyrine technique in freely moving rats. J. Cereb. Blood Flow. Metab. 9, 579-588. doi: 10.1038/jcbfm.1989.83
58. Niehof, M., and Borlak, J. (2009). Expression of HNF4alpha in the human and rat choroid plexus: implications for drug transport across the blood-cerebrospinal-fluid (CSF) barrier. BMC Mol. Biol. 10:68. doi: 10.1186/1471-2199-10-68
59. Nishino, J., Suzuki, H., Sugiyama, D., Kitazawa, T., Ito, K., Hanano, M., et al. (1999). Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. J. Pharmacol. Exp. Ther. 290, 289-294.
60. Ohtsuki, S., Takizawa, T., Takanaga, H., Terasaki, N., Kitazawa, T., Sasaki, M., et al. (2003). In vitro study of the functional expression of organic anion transporting polypeptide 3 at rat choroid plexus epithelial cells and its involvement in the cerebrospinal fluid-to-blood transport of estrone-3-sulfate. Mol. Pharmacol. 63, 532-537. doi: 10.1124/mol.63.3.532
61. Orford, M., Mean, R., Lapathitis, G., Genethliou, N., Panayiotou, E., Panayi, H., et al. (2009). Generation of an ABCG2(GFPn-puro) transgenic line-a tool to study ABCG2 expression in mice. Biochem. Biophys. Res. Commun. 384, 199-203. doi: 10.1016/j.bbrc.2009.04.089
62. Ose, A., Ito, M., Kusuhara, H., Yamatsugu, K., Kanai, M., Shibasaki, M., et al. (2009). Limited brain distribution of [3R,4R,5S]-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate (Ro 64-0802), a pharmacologically active form of oseltamivir, by active efflux across the blood-brain barrier mediated by organic anion transporter 3 (Oat3/Slc22a8) and multidrug resistance-associated protein 4 (Mrp4/Abcc4). Drug Metab. Dispos. 37, 315-321. doi: 10.1124/dmd.108.024018
63. Petropoulos, S., Gibb, W., and Matthews, S. G. (2010). Developmental expression of multidrug resistance phosphoglycoprotein (P-gp) in the mouse fetal brain and glucocorticoid regulation. Brain Res. 1357, 9-18. doi: 10.1016/j.brainres.2010.08.016
64. Qin, Y., and Sato, T. N. (1995). Mouse multidrug resistance 1a/3 gene is the earliest known endothelial cell differentiation marker during blood-brain barrier development. Dev. Dyn. 202, 172-180. doi: 10.1002/aja.1002020209
65. Reichel, V., Burghard, S., John, I., and Huber, O. (2011). P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats. Brain Res. 1370, 238-245. doi: 10.1016/j.brainres.2010.11.012
66. Roberts, L. M., Black, D. S., Raman, C., Woodford, K., Zhou, M., Haggerty, J. E., et al. (2008). Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 155, 423-438. doi: 10.1016/j.neuroscience.2008.06.015
67. Schinkel, A. H., and Jonker, J. W. (2003). Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3-29. doi: 10.1016/S0169-409X(02)00169-2
68. Schinkel, A. H., Wagenaar, E., Mol, C. A., and Van Deemter, L. (1996). P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J. Clin. Invest. 97, 2517-2524. doi: 10.1172/JCI118699
69. Schumacher, U., and Mollgard, K. (1997). The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain. Histochem. Cell Biol. 108, 179-182. doi: 10.1007/s004180050159
70. Scotto, K. W. (2003). Transcriptional regulation of ABC drug transporters. Oncogene 22, 7496-7511. doi: 10.1038/sj.onc.1206950
71. Shawahna, R., Uchida, Y., Decleves, X., Ohtsuki, S., Yousif, S., Dauchy, S., et al. (2011). Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol. Pharm. 8, 1332-1341. doi: 10.1021/mp200129p
72. Shen, H., Smith, D. E., Keep, R. F., and Brosius, F. C. III. (2004). Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol. Pharm. 1, 248-256. doi: 10.1021/mp049944b
73. Sims-Mourtada, J., Izzo, J. G., Ajani, J., and Chao, K. S. (2007). Sonic Hedgehog promotes multiple drug resistance by regulation of drug transport. Oncogene 26, 5674-5679. doi: 10.1038/sj.onc.1210356
74. Singh, R. R., Kunkalla, K., Qu, C., Schlette, E., Neelapu, S. S., Samaniego, F., et al. (2011). ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 30, 4874-4886. doi: 10.1038/onc.2011.195
75. Staud, F., and Pavek, P. (2005). Breast cancer resistance protein (BCRP/ABCG2). Int. J. Biochem. Cell Biol. 37, 720-725. doi: 10.1016/j.biocel.2004.11.004
76. Stolp, H. B., Liddelow, S. A., Sa-Pereira, I., Dziegielewska, K. M., and Saunders, N. R. (2013). Immune responses at brain barriers and implications for brain development and neurological function in later life. Front. Integr. Neurosci. 7:61. doi: 10.3389/fnint.2013.00061
77. Strazielle, N., Belin, M. F., and Ghersi-Egea, J. F. (2003). Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS 17, 1473-1485. doi: 10.1097/00002030-200307040-00008
78. Strazielle, N., and Ghersi-Egea, J. F. (1999). Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J. Neurosci. 19, 6275-6289.
79. Strazielle, N., and Ghersi-Egea, J. F. (2005). Factors affecting delivery of antiviral drugs to the brain. Rev. Med. Virol. 15, 105-133. doi: 10.1002/rmv.454
80. Strazielle, N., and Ghersi-Egea, J. F. (2013). Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol. Pharm. 10, 1473-1491. doi: 10.1021/mp300518e
81. Tachikawa, M., Watanabe, M., Hori, S., Fukaya, M., Ohtsuki, S., Asashima, T., et al. (2005). Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J. Neurochem. 95, 294-304. doi: 10.1111/j.1471-4159.2005.03369.x
82. Takashima, T., Yokoyama, C., Mizuma, H., Yamanaka, H., Wada, Y., Onoe, K., et al. (2011). Developmental changes in P-glycoprotein function in the blood-brain barrier of nonhuman primates: PET study with R-11C-verapamil and 11C-oseltamivir. J. Nucl. Med. 52, 950-957. doi: 10.2967/jnumed.110.083949
83. Tsai, C. E., Daood, M. J., Lane, R. H., Hansen, T. W., Gruetzmacher, E. M., and Watchko, J. F. (2002). P-glycoprotein expression in mouse brain increases with maturation. Biol. Neonate 81, 58-64. doi: 10.1159/000047185
84. Virgintino, D., Errede, M., Girolamo, F., Capobianco, C., Robertson, D., Vimercati, A., et al. (2008). Fetal blood-brain barrier P-glycoprotein contributes to brain protection during human development. J. Neuropathol. Exp. Neurol. 67, 50-61. doi: 10.1097/nen.0b013e31815f65d9
85. Wang, X., Campos, C. R., Peart, J. C., Smith, L. K., Boni, J. L., Cannon, R. E., et al. (2014). Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers. J. Neurosci. 34, 8585-8593. doi: 10.1523/JNEUROSCI.2935-13.2014
86. Westerhout, J., Danhof, M., and De Lange, E. C. (2011). Preclinical prediction of human brain target site concentrations: considerations in extrapolating to the clinical setting. J. Pharm. Sci. 100, 3577-3593. doi: 10.1002/jps.22604
87. Wijnholds, J., Delange, E. C., Scheffer, G. L., Van Den Berg, D. J., Mol, C. A., Van Der Valk, M., et al. (2000). Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J. Clin. Invest. 105, 279-285. doi: 10.1172/JCI8267
88. Xiang, J., Alesi, G. N., Zhou, N., and Keep, R. F. (2012). Protective effects of isothiocyanates on blood-CSF barrier disruption induced by oxidative stress. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R1-R7. doi: 10.1152/ajpregu.00518.2011
89. Yamada, T., Takaoka, A. S., Naishiro, Y., Hayashi, R., Maruyama, K., Maesawa, C., et al. (2000). Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Cancer Res. 60, 4761-4766.
90. Zhuang, Y., Fraga, C. H., Hubbard, K. E., Hagedorn, N., Panetta, J. C., Waters, C. M., et al. (2006). Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor. Cancer Res. 66, 11305-11313. doi: 10.1158/0008-5472.CAN-06-0929